# A Study to Evaluate AG-881 in Healthy Japanese and Non-Asian Participants

> **NCT04145128** · PHASE1 · COMPLETED · sponsor: **Agios Pharmaceuticals, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AG881

## Key facts

- **NCT ID:** NCT04145128
- **Lead sponsor:** Agios Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-02
- **Primary completion:** 2019-12-11
- **Final completion:** 2019-12-18
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04145128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04145128, "A Study to Evaluate AG-881 in Healthy Japanese and Non-Asian Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04145128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*